Subsequently, ECAR and OCR experiments, which represent the potential storage capacity and maximum storage capacity of glycolysis, demonstrated that the overexpression of ABHD17C increased the glycolysis level of pancreatic cancer cells (Fig. 5e–h). Here, ABHD17C is linked to familial pancreatic carcinoma.